Literature DB >> 96695

Factors associated with acquisition of Pseudomonas aeruginosa resistant to gentamicin.

F L Ruben, C W Norden, E Hruska.   

Abstract

Concern over the increased occurrence of Pseudomonas aeruginosa resistant to gentamicin colonizing and/or causing disease in patients prompted our review of the years 1974 and 1975 for all P aeruginosa isolates, both gentamicin-resistant and gentamicin-sensitive. In this period, 39 patients had gentamicin-resistant P aeruginosa recovered from clinical specimens while 683 patients had gentamicin-sensitive strains. Compared to both matched and/or randomly selected controls with gentamicin-sensitive infections, patients with gentamicin-resistant infections had a higher incidence of (1) prior antibiotic therapy (p less than 0.01), (2) prior therapy with gentamicin (p less than 0.005), and (3) exposure to multiple antibiotics.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96695     DOI: 10.1097/00000441-197803000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.

Authors:  T O Kurtz; D J Winston; D A Bruckner; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

2.  Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa.

Authors:  Meliha Cagla Sonmezer; Gunay Ertem; Fatma Sebnem Erdinc; Esra Kaya Kilic; Necla Tulek; Ali Adiloglu; Cigdem Hatipoglu
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-08-30       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.